ASTRAZEN Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > astrazen

Technical Analysis

Technical Strength: 5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.0. According to RSI analysis, astrazen is at it's support. 8.0 ASTRAZEN RSI Chart
MACD (?) MACD: 6.35 and Signal Line: 13.8. According to MACD analysis, astrazen is marginally weak. 3.0 ASTRAZEN MACD Chart
Simple Moving Average (?) According to simple moving average analysis, astrazen is facing resistance from it's 20-day simple moving average at 1143.115 and support level is at 1.08e+03. 3.0 ASTRAZEN Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, astrazen is facing resistance from it's 20-day exponential moving average at 1130.506 and support level is at 1.09e+03. 3.0 ASTRAZEN Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.19. According to bollinger bands, astrazen is technically weak. 3.0 ASTRAZEN Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 1089.55 and 1045.0758. Resistance level is 1134.0242. 8.0 ASTRAZEN Fibonacci Retracement Chart
Average True Range (?) ATR: 38.2 NA ASTRAZEN Average True Range Chart
Average Directional Index (?) ADX is 37.8 which means ASTRAZEN is in a trend. NA ASTRAZEN Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
December 14, 2017
Open Price 1119.7
High Price 1130.0
Low Price 1101.05
Close Price 1117.1
Absolute Change 0.85
Percentage Change 0.0761%
Weekly Change -0.988%
Monthly Change -4.68%
Yearly Change 17.6%
52-week high 1278.0
52-week low 880.2
Corporate Actions
ExDate Purpose
September 04, 2017 ANNUAL GENERAL MEETING
September 18, 2014 Annual General Meeting
July 09, 2012 AGM/DIV-RS.3.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.469
Confidence in Beta0.235%
Market Capital Rs. 2792.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 2.1
TTM Price-to-Earnings (P/E) Ratio 532
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 14 December 2017: Deliverable Quantity:3e+03 NA ASTRAZEN Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 14 December 2017: Daily Volatility:0.3038 NA ASTRAZEN Annualized Daily Volatility (Spot Price) Chart

Announcements

September 15, 2017 AsShareholders meetingstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 13, 2017. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
August 22, 2017 AsShareholders meetingstraZeneca Pharma India Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 13, 2017
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 27, 2017 November 06, 2017 inResults/Othersnter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2017.
July 26, 2017 August 08, 2017 inResultsnter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1073 Rs. 1087 Rs. 1102 Rs. 1116 Rs. 1131 Rs. 1145 Rs. 1160